CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-25 | McCarthy Sean A. President and CEO | Grant or award · Stock Option (right to buy) | +310,000 | 310,000 | ||
| 2017-01-25 | HUMPHREY RACHEL Chief Medical Officer | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2017-01-25 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2017-01-25 | LADD CYNTHIA J Senior VP and General Counsel | Grant or award · Stock Option (right to buy) | +84,000 | 84,000 | ||
| 2017-01-25 | Goeltz II Robert C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +84,000 | 84,000 | ||
| 2016-12-28 | HUMPHREY RACHEL Chief Medical Officer | Option exercise | +15,117 | $6.61 | $100K | 15,117 |
| 2016-12-28 | HUMPHREY RACHEL Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −15,117 | 278,097 | ||
| 2016-11-30 | McCarthy Sean A. President and CEO | Grant or award | +1,979 | $9.10 | $18K | 1,979 |
| 2016-11-30 | Goeltz II Robert C. Chief Financial Officer | Grant or award | +1,289 | $9.10 | $12K | 7,289 |
| 2016-11-30 | Canaan IX L.P. Director | Other disposition | −400,000 | 3,244,381 | ||
| 2016-11-29 | SHANNON TIMOTHY M Director | Sale | −22,086 | $11.18 | $247K | 3,244,381 |
| 2016-11-29 | Canaan IX L.P. Director | Sale | −22,086 | $11.18 | $247K | 3,644,381 |
| 2016-11-28 | SHANNON TIMOTHY M Director | Sale | −20,840 | $11.33 | $236K | 3,666,467 |
| 2016-11-28 | Canaan IX L.P. Director | Sale | −20,840 | $11.33 | $236K | 3,666,467 |
| 2016-11-25 | SHANNON TIMOTHY M Director | Sale | −6,729 | $11.79 | $79K | 3,687,307 |
| 2016-11-25 | Canaan IX L.P. Director | Sale | −6,729 | $11.79 | $79K | 3,687,307 |
| 2016-11-23 | SHANNON TIMOTHY M Director | Sale | −10,890 | $11.84 | $129K | 3,694,036 |
| 2016-11-23 | Canaan IX L.P. Director | Sale | −10,890 | $11.84 | $129K | 3,694,036 |
| 2016-11-22 | SHANNON TIMOTHY M Director | Sale | −42,550 | $11.71 | $498K | 3,704,926 |
| 2016-11-22 | Canaan IX L.P. Director | Sale | −42,550 | $11.71 | $498K | 3,704,926 |
Page 27 of 33 · 649 trades